Target intelligence / Profile preview

T helper type 2 cell (Th2 cell) (Th2)

Target
Th2
Molecular classification
Other (immune cell subset)
01

Overview

T helper type 2 cells (Th2 cells) are a specialized subset of CD4+ T lymphocytes that play a central role in orchestrating the humoral immune response. They are characterized by their secretion of cytokines such as interleukin‐4 (IL‐4), IL‐5, and IL‐13. These cytokines promote B-cell differentiation and class-switching to immunoglobulin E (IgE), recruit and activate eosinophils, induce mucus production from epithelial tissues, and counteract pro-inflammatory responses mediated by Th1 cells. The induction or dominance of a Th2 response is associated with protection against extracellular parasites but also underlies the pathogenesis of allergic diseases such as asthma, atopic dermatitis, food allergies, and certain autoimmune conditions. Therapeutic strategies targeting key cytokines produced by Th2 cells—such as anti–IL‑4/13 or anti–IL‑5 antibodies—are used in treating severe asthma and other allergic disorders. However, "Immune system modulation via induction of Th2 response" is not itself a molecule or receptor but rather describes an immunological process; thus it is not considered a canonical therapeutic target like an enzyme or receptor would be.[1][2][3][5]

Other names
Type 2 helper T cellTh2 lymphocyteCD4+ Th2 cell
02

Mechanism of action

Inhibition of IL‑4/IL‑13 signaling to reduce Th2-mediated inflammation[3][5]; Blockade of IL‑5 to decrease eosinophil activity[3][5]

03

Biological functions

Immune responseAntibody productionEosinophil recruitment and activationRegulation of B-cell class switching to IgE
04

Disease associations

AllergyAsthmaAutoimmune disease (e.g., systemic lupus erythematosus, chronic graft-versus-host disease)Eosinophilic disorders
05

Safety considerations

Immunosuppression leading to increased infection risk when modulating the immune system broadly[3]
06

Interacting drugs

Dupilumab (anti–IL‑4/IL‑13 antibody)[3]

3 more in the full profile.

07

Biomarkers

Elevated serum IgE levels[1][5]Increased blood or tissue eosinophils[1][5]

Beyond the preview

Go deeper on T helper type 2 cell (Th2 cell) (Th2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T helper type 2 cell (Th2 cell) (Th2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call